HF
ONCO icon

HRT Financial’s Onconetix ONCO Stock Holding History

HRT Financial’s Portfolio ONCO Stock Details ONCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34
Closed -$11K – 3296
2025
Q1 		$11K Buy
+34
New +$58.3K ﹤0.01% 2348
2024
Q3 		– Sell
-1
Closed -$17K – 2927
2024
Q2 		$17K Buy
+1
New +$25.4K ﹤0.01% 1953
2022
Q2 		– Hold
0
– -$639K – 3500
2022
Q1 		– Hold
0
– – – 1453

Other funds holding ONCO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

HRT Financial's ONCO Position: Q2 2025 in Review

HRT Financial sold out of Onconetix (ONCO) in Q2 2025, closing a stake of 34 shares — an estimated $11K sold.

HRT Financial first reported a position in ONCO in Q2 2024 and held it in 2 quarters. The position peaked at $17K in Q2 2024. 5 funds tracked by Wall St. Rank hold ONCO as of Q2 2025.

  • HRT Financial reported no remaining Onconetix position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 34 Onconetix shares in Q2 2025, an estimated $11K.
  • HRT Financial first reported a position in Onconetix in Q2 2024 and held it in 2 quarters.
  • HRT Financial's Onconetix position peaked at $17K in Q2 2024.
  • 5 funds tracked by Wall St. Rank held Onconetix as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.